menu
    • menu

    Company profile for ViroCell Biologics

    NEW Drugs in Dev.: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ViroCell Biologics is an innovation-driven viral vector CDMO specializing in the design, de-risking, and GMP-scale manufacture of lentiviral and retroviral vectors for cell and gene therapy. Their team—backed by 25+ years of experience and ~200 complex vector projects—offers expert vector engineering, rapid process development, and scalable manufacturing. With global facilities and academic-led expertise, ViroCell accelera...
    ViroCell Biologics is an innovation-driven viral vector CDMO specializing in the design, de-risking, and GMP-scale manufacture of lentiviral and retroviral vectors for cell and gene therapy. Their team—backed by 25+ years of experience and ~200 complex vector projects—offers expert vector engineering, rapid process development, and scalable manufacturing. With global facilities and academic-led expertise, ViroCell accelerates clinical entry of novel therapies by delivering high-quality vectors with enhanced safety and performance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ViroCell Biologicsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    12-18 Theobalds Road London WC1X 8SL, UK
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.virocell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/virocell-biologics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ViroCell & AvenCell Collaborate on CAR-T for Blood Cancers
    ViroCell & AvenCell Collaborate on CAR-T for Blood Cancers

    29 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250728879540/en/ViroCell-Biologics-and-AvenCell-Therapeutics-Announce-Retroviral-Vector-Manufacturing-Collaboration-to-Accelerate-Development-of-Novel-Allogeneic-CAR-T-Therapies-for-Blood-Cancers

    BUSINESSWIRE
    29 Jul 2025
    Share Share
    ViroCell Makes GMP Vector for UCL Childhood Cancer Study
    ViroCell Makes GMP Vector for UCL Childhood Cancer Study

    17 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250416574846/en/ViroCell-Manufactured-a-GMP-Lentiviral-Vector-for-UCL-to-Accelerate-Research-Into-Prevention-of-Relapse-in-Childhood-Blood-Cancer

    BUSINESSWIRE
    17 Apr 2025
    Share Share
    ViroCell Biologics Completes Oversubscribed Financing
    ViroCell Biologics Completes Oversubscribed Financing

    14 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240814147754/en

    BUSINESSWIRE
    14 Aug 2024
    Share Share
    ViroCell Biologics Signs MSA With NCI-Designated Cancer Center
    ViroCell Biologics Signs MSA With NCI-Designated Cancer Center

    22 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240722521261/en

    BUSINESSWIRE
    22 Jul 2024
    Share Share
    ViroCell to present at 2024 Cell & Gene Meeting on the Med
    ViroCell to present at 2024 Cell & Gene Meeting on the Med

    09 Apr 2024

    // PRESS RELEASE

    https://virocell.com/press-releases-blog/virocell-to-present-at-2024-cell-amp-gene-meeting-on-the-med

    PRESS RELEASE
    09 Apr 2024
    Share Share
    ViroCell to presents at 2024 Cell & Gene Meeting on the Med
    ViroCell to presents at 2024 Cell & Gene Meeting on the Med

    08 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240407754556/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search